Gene · 9002
Papers2,206
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,206
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gender-associated heterogeneity of F2RL3 methylation in peripheral blood highlights its associations with early-stage male lung cancer in the Chinese population. | Cancer Epidemiol | 2025 | 40328203 | PubTator, text mining | PubMed |
| Elderly patients are hyperresponsive to potent P2Y12 inhibitors. | Res Pract Thromb Haemost | 2025 | 40177222 | PubTator, text mining | PubMed |
| Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection. | JCI Insight | 2025 | 40168094 | PubTator, text mining | PubMed |
| BAD-Glucokinase Axis Regulates Platelet Activation and Thrombosis. | Arterioscler Thromb Vasc Biol | 2025 | 40109256 | PubTator, text mining | PubMed |
| Endothelial protease-activated receptor 4: impotent or important? | Front Cardiovasc Med | 2025 | 39935714 | PubTator, text mining | PubMed |
| Single-cell atlas of human pancreatic islet and acinar endothelial cells in health and diabetes. | Nat Commun | 2025 | 39915484 | PubTator, text mining | PubMed |
| Antithrombotic but not anticoagulant activity of the thrombin-binding RNA aptamer Apta-1. | Br J Pharmacol | 2025 | 39653034 | PubTator, text mining | PubMed |
| Integrative phosphoproteomic analyses reveal hemostatic-endothelial signaling interplay. | J Thromb Haemost | 2025 | 39442624 | PubTator, text mining | PubMed |
| Acetaminophen Overdose Reveals PAR4 as a Low-Expressing but Potent Receptor on the Hepatic Endothelium in Mice. | Arterioscler Thromb Vasc Biol | 2025 | 39360412 | PubTator, text mining | PubMed |
| Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytes. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39283528 | PubTator, text mining | PubMed |
| Uses of Molecular Docking Simulations in Elucidating Synergistic, Additive, and/or Multi-Target (SAM) Effects of Herbal Medicines. | Molecules | 2024 | 39598795 | PubTator, text mining | PubMed |
| Modulation of persistent bladder pain in mice: The role of macrophage migration inhibitory factor, high mobility group box-1, and downstream signaling pathways. | Bladder (San Franc) | 2024 | 39539469 | PubTator, text mining | PubMed |
| Discovery of quinazoline-benzothiazole derivatives as novel potent protease-activated receptor 4 antagonists with improved pharmacokinetics and low bleeding liability. | Eur J Med Chem | 2024 | 39442337 | PubTator, text mining | PubMed |
| Epigenetic changes driven by environmental pollutants in lung carcinogenesis: a comprehensive review. | Front Public Health | 2024 | 39440184 | PubTator, text mining | PubMed |
| Gestodene, a novel positive allosteric modulator of PAR1, enhances PAR1-mediated human platelet aggregation. | Front Pharmacol | 2024 | 39130626 | PubTator, text mining | PubMed |
| Prognostic Model and Immune Response of Clear Cell Renal Cell Carcinoma Based on Co-Expression Genes Signature. | Clin Genitourin Cancer | 2024 | 39129082 | PubTator, text mining | PubMed |
| PAR1-mediated Non-periodical Synchronized Calcium Oscillations in Human Mesangial Cells. | Function (Oxf) | 2024 | 38984988 | PubTator, text mining | PubMed |
| Platelet Activation Pathways Controlling Reversible Integrin αIIbβ3 Activation. | TH Open | 2024 | 38911141 | PubTator, text mining | PubMed |
| Acetaminophen Overdose Reveals Protease-Activated Receptor 4 as a Low-Expressing but Potent Receptor on the Hepatic Endothelium. | bioRxiv | 2024 | 38895465 | PubTator, text mining | PubMed |
| STING Contributes to Pulmonary Hypertension by Targeting IFN and BMPR2 Signaling through Regulating of F2RL3. | Am J Respir Cell Mol Biol | 2024 | 38864771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9002/papers?page=3